Amneal Pharmaceuticals (AMRX) PT Raised to $7 at BTIG
Tweet
Share
E-mailGet Alerts AMRX Hot Sheet
Price: $19.77 -0.2%
Rating Summary:
8 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Rating Summary:
8 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Join SI Premium – FREE
BTIG analyst Timothy Chiang raised the price target on Amneal Pharmaceuticals (: AMRX) to $7.00 (from $5.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oppenheimer Starts Amneal Pharmaceuticals (AMRX) at Outperform
- Okta, Inc (OKTA) PT Raised to $230 at BMO Capital on 'AI and Virtuous Cycle Opportunity'
- Slate Grocery REIT (SGR-U:CN) (SRRTF) PT Lowered to $8.75 at Scotiabank
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
BTIGSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
